Old National Bancorp’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.6M Buy
218,238
+11,241
+5% +$645K 0.25% 75
2026
Q1
$12.6M Buy
206,997
+6,365
+3% +$371K 0.21% 85
2025
Q4
$10.8M Sell
200,632
-19,971
-9% -$961K 0.18% 92
2025
Q3
$9.95M Buy
220,603
+16,575
+8% +$774K 0.17% 108
2025
Q2
$9.44M Buy
204,028
+7,136
+4% +$350K 0.17% 112
2025
Q1
$12M Sell
196,892
-2,745
-1% -$160K 0.32% 71
2024
Q4
$11.3M Sell
199,637
-7,277
-4% -$407K 0.27% 86
2024
Q3
$10.7M Buy
206,914
+1,113
+0.5% +$52.2K 0.25% 91
2024
Q2
$8.55M Buy
205,801
+15,680
+8% +$702K 0.2% 112
2024
Q1
$10.3M Buy
190,121
+20,102
+12% +$1.02M 0.24% 98
2023
Q4
$8.72M Buy
170,019
+476
+0.3% +$25K 0.23% 102
2023
Q3
$9.84M Sell
169,543
-3,884
-2% -$238K 0.28% 85
2023
Q2
$11.1M Buy
173,427
+3,415
+2% +$229K 0.32% 82
2023
Q1
$11.8M Buy
170,012
+1,127
+0.7% +$79.5K 0.36% 73
2022
Q4
$12.2M Sell
168,885
-714
-0.4% -$53.8K 0.38% 68
2022
Q3
$12.1M Sell
169,599
-9,307
-5% -$675K 0.41% 58
2022
Q2
$13.8M Buy
178,906
+46,794
+35% +$3.56M 0.46% 50
2022
Q1
$9.65M Buy
132,112
+3,985
+3% +$268K 0.36% 70
2021
Q4
$7.99M Sell
128,127
-954
-0.7% -$56K 0.29% 89
2021
Q3
$7.64M Buy
129,081
+11,744
+10% +$773K 0.29% 89
2021
Q2
$7.84M Buy
117,337
+4,846
+4% +$316K 0.29% 87
2021
Q1
$7.1M Buy
112,491
+7,819
+7% +$486K 0.28% 93
2020
Q4
$6.49M Buy
104,672
+563
+0.5% +$34.6K 0.27% 95
2020
Q3
$6.28M Sell
104,109
-541
-0.5% -$32.6K 0.3% 87
2020
Q2
$6.15M Buy
104,650
+3,139
+3% +$188K 0.31% 87
2020
Q1
$5.66M Sell
101,511
-1,222
-1% -$74.7K 0.35% 81
2019
Q4
$6.59M Buy
102,733
+3,941
+4% +$226K 0.32% 88
2019
Q3
$5.01M Buy
98,792
+121
+0.1% +$5.69K 0.25% 106
2019
Q2
$4.47M Buy
98,671
+4,597
+5% +$214K 0.23% 112
2019
Q1
$4.49M Buy
94,074
+701
+0.8% +$34.9K 0.23% 108
2018
Q4
$4.85M Sell
93,373
-8,649
-8% -$465K 0.27% 95
2018
Q3
$6.33M Buy
102,022
+1,415
+1% +$84K 0.31% 86
2018
Q2
$5.57M Buy
100,607
+9,254
+10% +$500K 0.29% 92
2018
Q1
$5.78M Buy
91,353
+4,514
+5% +$290K 0.3% 86
2017
Q4
$5.32M Sell
86,839
-429
-0.5% -$26.8K 0.27% 96
2017
Q3
$5.56M Buy
87,268
+1,913
+2% +$112K 0.3% 86
2017
Q2
$4.76M Sell
85,355
-2,728
-3% -$148K 0.26% 99
2017
Q1
$4.79M Sell
88,083
-42,083
-32% -$2.31M 0.26% 96
2016
Q4
$7.61M Sell
130,166
-30,452
-19% -$1.66M 0.44% 68
2016
Q3
$8.66M Sell
160,618
-25,630
-14% -$1.65M 0.5% 65
2016
Q2
$13.7M Buy
186,248
+4,970
+3% +$351K 0.78% 39
2016
Q1
$11.6M Sell
181,278
-467
-0.3% -$29.5K 0.68% 44
2015
Q4
$12.5M Sell
181,745
-928
-0.5% -$61.3K 0.74% 40
2015
Q3
$10.8M Sell
182,673
-2,386
-1% -$151K 0.66% 46
2015
Q2
$12.3M Buy
185,059
+2,899
+2% +$191K 0.69% 45
2015
Q1
$11.7M Sell
182,160
-5,064
-3% -$317K 0.64% 50
2014
Q4
$11.1M Buy
187,224
+61,955
+49% +$3.49M 0.7% 46
2014
Q3
$6.41M Buy
125,269
+3,149
+3% +$157K 0.42% 68
2014
Q2
$5.92M Buy
122,120
+9,847
+9% +$485K 0.45% 58
2014
Q1
$5.83M Buy
112,273
+1,333
+1% +$70.9K 0.53% 53
2013
Q4
$5.9M Sell
110,940
-6,967
-6% -$355K 0.54% 52
2013
Q3
$5.46M Sell
117,907
-44,589
-27% -$1.96M 0.56% 51
2013
Q2
$7.26M Buy
+162,496
New +$7.05M 0.77% 49

Other funds holding BMY

Old National Bancorp's BMY Position: Q2 2026 in Review

Old National Bancorp increased its Bristol-Myers Squibb (BMY) stake by 5.4% in Q2 2026, buying an estimated $645K and bringing the position to 218,238 shares worth $12.6M. The position accounts for 0.25% of the portfolio, ranked #75.

Old National Bancorp first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $13.8M in Q2 2022. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Old National Bancorp held 218,238 shares of Bristol-Myers Squibb worth $12.6M as of Q2 2026.
  • Old National Bancorp bought 11,241 Bristol-Myers Squibb shares in Q2 2026, an estimated $645K.
  • Bristol-Myers Squibb made up 0.25% of Old National Bancorp's portfolio in Q2 2026, its #75 holding.
  • Old National Bancorp first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • Old National Bancorp's Bristol-Myers Squibb position peaked at $13.8M in Q2 2022.
  • 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Old National Bancorp's 13F filing for Q2 2026, filed 15 Jul 2026.